8-K: Viewbix to Acquire Quantum X Labs, Expand Quantum Tech

Viewbix Inc. announced a definitive agreement to acquire Quantum X Labs Ltd., issuing up to 40% of its capital stock and potential earn-outs for Quantum's quantum technology assets.

Summary

• Viewbix Inc. (the Company) entered into a securities exchange agreement to acquire Quantum X Labs Ltd. (Quantum).
• Viewbix will issue up to 40.0% of its issued and outstanding capital stock to Quantum Shareholders, consisting of up to 2,666,000 common shares and pre-funded warrants to purchase up to 4,447,595 common shares.
• This exchange is for up to 100% (but not less than 85%) of Quantum's fully diluted share capital, totaling up to 589,319 ordinary shares.
• The acquisition is expected to close within 90 calendar days of December 15, 2025, subject to due diligence, regulatory and stockholder approvals, and Quantum Shareholders holding at least 85% of Quantum's capital.
• Quantum will become a subsidiary of Viewbix upon closing.
• Additional earn-out securities, up to 12,702,847 shares or pre-funded warrants, may be issued based on achieving specific milestones related to patent applications, portfolio company M&A/listing, and capital raises.
• The Viewbix Exchange Shares and shares from pre-funded warrants will be subject to a 12-month lock-up period post-closing.
• Pre-funded warrants are immediately exercisable at $0.0001 per share and do not expire.
• Quantum Shareholders will apply for an Israeli tax deferral ruling, with shares held in escrow for 30 days post-closing.
• The transaction involves the conversion of a USD 1.5M capital note (including USD 400,000 from L.I.A Pure Capital Ltd. and other Quantum Shareholders) into an equity investment in Quantum, which will terminate at closing.

Sentiment

Score: 7

Explanation: The acquisition of Quantum X Labs represents a strategic expansion into a high-growth sector, with potential for significant future value creation tied to innovation and market success. The earn-out structure aligns incentives. However, the substantial potential dilution and various closing conditions introduce notable risks and uncertainties.

Positives

• Acquisition of Quantum X Labs Ltd. could significantly expand Viewbix's presence in the quantum sector.
• The earn-out structure aligns incentives with Quantum Shareholders, contingent on achieving specific performance milestones (patent applications, portfolio company success, significant capital raises).
• The pre-funded warrants are immediately exercisable at a nominal price ($0.0001), providing flexibility for holders.
• Viewbix will continue to fund Quantum, indicating ongoing support for the acquired entity's operations and development.

Negatives

• Significant potential dilution for existing Viewbix shareholders, with up to 40.0% of capital stock issued at closing and up to 65.0% including earn-out securities.
• The acquisition is subject to several conditions, including final due diligence, regulatory approvals, and Viewbix stockholder approval, which introduce uncertainty regarding its completion.
• The 12-month lock-up period for Viewbix Exchange Securities could create a future overhang on the stock price once the lock-up expires.
• Quantum has existing liabilities, including up to $180,000 in ordinary course business liabilities and debt to contractors after May 8, 2025.
• The Israeli tax ruling for deferral is not guaranteed; if not obtained, the transaction will be a taxable event for Quantum Shareholders.

Risks

• Completion Risk: The acquisition is subject to various conditions, including satisfactory due diligence, regulatory approvals, and Viewbix stockholder approval, which may not be met.
• Integration Risk: Integrating Quantum X Labs Ltd. into Viewbix's operations may present challenges, potentially impacting business performance.
• Dilution Risk: The issuance of up to 40.0% of Viewbix's capital stock at closing, and potentially up to 65.0% with earn-out securities, could significantly dilute the ownership and earnings per share of existing shareholders.
• Earn-Out Achievement Risk: The achievement of earn-out milestones (patent applications, portfolio company M&A/listing, capital raises) is uncertain and depends on future performance and market conditions.
• Tax Risk: The Israeli Tax Authority may not issue a tax ruling confirming tax deferral, making the transaction a taxable event for Quantum Shareholders, which could have unforeseen implications.
• Market Overhang Risk: The 12-month lock-up period for Viewbix Exchange Securities could lead to a significant increase in shares available for sale once the lock-up expires, potentially putting downward pressure on the stock price.
• Regulatory Compliance Risk: Failure to comply with Nasdaq Stock Market LLC rules regarding stockholder approval could impact the transaction or Viewbix's listing status.
• Intellectual Property Risk: While Quantum represents it has rights to use necessary IP, there's always a risk of infringement claims or challenges to IP validity.

Future Outlook

The completion of the acquisition of Quantum X Labs Ltd. by Viewbix Inc. is expected to occur within 90 calendar days of December 15, 2025, subject to various conditions including due diligence, regulatory approvals, and stockholder consent. Future potential for significant share issuance is tied to Quantum's performance milestones in patent development, portfolio company success, and large-scale capital raises over the next 18 to 48 months.

Management Comments

• The Company is using forward-looking statements when it discusses the completion of final due diligence, regulatory approvals, approval by the Company’s stockholders and the satisfaction of customary closing conditions.
• These forward looking statements are based upon the Company’s present intent, beliefs or expectations, but forward looking statements are not guaranteed to occur and may not occur for various reasons, including some reasons which are beyond the Company’s control.
• For this reason, among others, you should not place undue reliance upon the Company’s forward looking statements.
• Except as required by law, the Company undertakes no obligation to revise or update any forward looking statements in order to reflect any event or circumstance that may arise after the date of this Current Report.

Industry Context

This acquisition positions Viewbix to expand into the rapidly evolving quantum technology sector by integrating Quantum X Labs Ltd.'s assets and expertise. The focus on patent applications and the success of portfolio companies suggests a strategy to build a strong intellectual property portfolio and potentially incubate new ventures within the quantum space. This move aligns with a broader industry trend of technology companies seeking to gain an early foothold in emerging, high-growth areas like quantum computing and related applications, which are expected to drive significant innovation and market disruption in the coming decades.

Comparison to Industry Standards

• The earn-out structure, tied to patent applications and significant capital raises/M&A events, is a common mechanism in technology acquisitions, particularly in early-stage or high-growth sectors like quantum technology, to align seller incentives with future performance.
• The 12-month lock-up period for seller shares is standard practice to prevent immediate selling pressure post-acquisition, similar to lock-ups seen in IPOs or other significant share issuances.
• The requirement for stockholder approval for significant share issuances (up to 40% at closing, 65% with earn-outs) is consistent with Nasdaq listing rules and corporate governance best practices to protect existing shareholder interests from excessive dilution.
• The nominal exercise price ($0.0001) for pre-funded warrants is typical for such instruments, designed to effectively function as common stock with a deferred issuance mechanism, often used in private placements or acquisitions to manage share count or regulatory thresholds.

Corporate Governance

Related Party Transactions

• The Capital Note includes USD 400,000 provided to Quantum by L.I.A Pure Capital Ltd. and 'other Quantum Shareholders.' This loan will be treated as an equity investment and terminated at closing, indicating a related party transaction.

Stakeholder Impact

• Shareholders (Viewbix): Significant potential dilution (up to 40% at closing, 65% with earn-outs) but also potential for long-term value creation through expansion into quantum technology. Requires stockholder approval.
• Shareholders (Quantum): Will become shareholders of Viewbix, subject to a 12-month lock-up, and have potential for additional earn-out securities based on Quantum's future performance.
• Employees/Contractors (Quantum): Quantum has engaged contractors and has debt to them, which will need to be managed post-acquisition. Becoming a subsidiary typically involves integration.
• Creditors (Quantum): The USD 1.5M Capital Note will be converted to equity, impacting certain creditors. Other liabilities up to $180,000 exist.
• Regulatory Bodies: The transaction requires regulatory approvals and an Israeli tax ruling, impacting the timeline and structure.

Next Steps

• Viewbix to complete legal, financial, business, and technical due diligence of Quantum within 30 days of December 15, 2025.
• Viewbix to obtain stockholder approval for the issuance of securities, either via written consent (information statement filed within 45 days) or a special meeting (held within 90 days).
• Quantum Shareholders to apply for an Israeli Tax Authority ruling for tax deferral.
• The closing of the acquisition is expected within 90 calendar days of December 15, 2025, subject to all conditions being met.
• Viewbix will continue to fund Quantum in accordance with the Ramot License under the Capital Note.
• Potential issuance of earn-out securities upon achievement of milestones related to patent applications (within 18 months post-closing), portfolio company M&A/listing (within 24 months post-closing), and significant capital raises or Quantum M&A (within 48 months post-closing).

Key Dates

Recommendation

The acquisition of Quantum X Labs Ltd. is a strategic move for Viewbix Inc. into the promising quantum technology sector, offering long-term growth potential. The earn-out structure aligns incentives, and the pre-funded warrants provide flexibility. However, the substantial potential dilution for existing shareholders (up to 65% with earn-outs) and the inherent risks associated with integrating a new business in an emerging technology field warrant caution. The transaction is also subject to several closing conditions, including stockholder and regulatory approvals, introducing uncertainty. Given the balance of strategic upside and significant execution risks and dilution, a 'hold' recommendation is appropriate for investors to monitor the closing of the transaction, the integration process, and the achievement of the earn-out milestones before making further investment decisions.

Keywords

Viewbix Inc., Quantum X Labs Ltd., Acquisition, Merger, SEC Filing, 8-K, Securities Exchange Agreement, Quantum Technology, Stock Exchange, Pre-Funded Warrants, Earn-Out, Dilution, Corporate Governance, Nasdaq, Israel Tax Authority, Regulation S, Patent Applications, Capital Raise